Newsroom archive

Skin Quality survey thumbnail
07 . 07 .2026
Press release
Landmark global Galderma survey shows 9 out of 10 people are affected by skin quality concerns
  • Global release
Galderma logo
01 . 07 .2026
Press release
Galderma provides progress update regarding RelabotulinumtoxinA regulatory submission in the United States
  • Key Release
Prurigo nodularis: The burden of diagnostic delay
16 . 06 .2026
News story
Prurigo nodularis: The burden of diagnostic delay
11 . 06 .2026
Press release
Galderma unveils new global survey data exploring the evolving expectations and experiences of patients and healthcare professionals with anti-wrinkle treatments
  • Global release
Acknowledging the full burden of acne
01 . 06 .2026
News story
Beyond breakouts: acknowledging the full burden of acne
Differin Epiduo
22 . 05 .2026
Press release
Galderma receives U.S. FDA approval for Differin® Epiduo® Acne Gel Prescription-to-OTC switch
  • Global release
SKIN: The value of scientific exchange in dermatology
24 . 04 .2026
News story
Understanding connections across inflammatory skin conditions: the SKIN approach
Q1 2026 performance update
23 . 04 .2026
Press release
Galderma reports strong start to the year, delivering first quarter 2026 net sales of 1.473 billion USD, growing 25.5% at constant currency
  • Key Release
Galderma logo
22 . 04 .2026
Press release
Galderma shareholders approve all Annual General Meeting proposals
  • Global release
Alastin TriHex+
16 . 04 .2026
Press release
Galderma launches new Alastin Regenerating Skin Nectar with TriHex+™, powered by its next-generation TriHex Technology® regenerative platform
  • Global release